Skip to NavigationSkip to content

Pharmafile - News News

A large controlled clinical trial has linked the early use of tranexamic acid to a small fall in the risk of death in patients who have suffered...
Takeda has sold selected prescription and over the counter products to Acino in the Near East, Middle East and Africa as it looks to trim down its...
The Government has announced new legislation aimed at providing faster access to medicines, including those treating dementia and Alzheimer's.
Eli Lilly has announced that the FDA has given the green light to Reyvow (lasmiditan) in the acute treatment of migraine, with or without aura, in...
A new clinical trial at King’s College London will investigate the use of cannabidiol (CBD) – a compound found in the cannabis plant – to treat...
Janssen’s Xarelto (rivaroxaban) has secured FDA approval for the prevention of venous thromboembolism (VTE), or blood clots, in hospitalised...
Reata has reported that Part 2 of its mid-stage MOXIe trial of its Nrf2 activator omaveloxolone met its primary endpoint.
Pfizer confirmed over the weekend that its oral Janus kinase 1 (JAK1) inhibitor abrocitinib met all of its co-primary and key secondary endpoints...
Daiichi Sankyo have announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients treated...
Shionogi has reported positive data from a trial of its investigational antibiotic cefiderocol which is already under regulatory review in the US and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches